News

May 30, 2018May 30, 2018

UsAgainstAlzheimer’s Launches AD PACE, New Patient-Caregiver Initiative

News

UsAgainstAlzheimer’s recently launched the Alzheimer’s Disease Patient and Caregiver Engagement (AD PACE) initiative as a groundbreaking partnership between the public and private sectors to identify and prioritize the needs ... Read more

May 25, 2018May 25, 2018

Study Investigates ‘Friendsourcing’ as a Way to Provide Support to Alzheimer’s Caregivers

News

A new Facebook app can provide emotional support to unpaid caregivers of Alzheimer’s disease patients, according to a study. Researchers at Indiana University Purdue University Indianapolis developed the app as part ... Read more

May 23, 2018May 23, 2018

Janssen Halts Clinical Development of Alzheimer’s Candidate Atabecestat Due to Liver Issues

News

Janssen pulled the plug on a Phase 2b/3 trial and a Phase 2 safety study of its Alzheimer’s disease experimental therapy atabecestat due to toxicity issues as a result of ... Read more

May 18, 2018May 18, 2018

Phase 2 Trial Testing Alkahest’s Investigational GRF6019 for Alzheimer’s Doses First Patient

News

Alkahest‘s Phase 2 clinical trial testing GRF6019 — an experimental blood-derived protein — in patients with mild to moderate Alzheimer’s disease has dosed its first participant, the company recently announced. ... Read more

May 16, 2018May 16, 2018

Institute on Aging Awards $2.5M to Launch Collaborative Research Project

News

A new National Institute on Aging (NIA)-funded collaborative project will bring together scientists from different disciplines to study a range of issues affecting older adults, including Alzheimer’s disease. The ... Read more

May 14, 2018May 15, 2018

Failed Verubecestat Trial May Call into Question Beta-amyloid Theory in Alzheimer’s, Study Suggests

News

Verubecestat (MK-8931) indeed failed to slow cognitive and functional decline in mild-to-moderate Alzheimer’s patients despite some reduction in beta-amyloid levels seen, final results of a Phase 2/3 study closed ... Read more

May 11, 2018May 11, 2018

Phase 3 of Large-scale Alzheimer’s Disease Study Looking to Enroll Hundreds of Participants

News

The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is searching for participants to enroll in one of the largest and longest trials on Alzheimer’s disease. This ongoing study aims to develop ... Read more

May 9, 2018May 9, 2018

FDA Clearance Supports Start of Phase 2 Trial of TNX-102 SL for Agitation in Alzheimer’s Patients

News

The U.S. Food and Drug Administration (FDA) approved Tonix Pharmaceuticals’ investigational new drug (IND) application to support the start of a Phase 2 trial of TNX-102 SL in Alzheimer’s ... Read more

May 7, 2018May 7, 2018

New Genetically Engineered Rat Model Can Aid Alzheimer’s Research, Study Says

News

A rat model genetically engineered to express high levels of two genes can help researchers learn more about the disease mechanisms that lead to Alzheimer’s disease, a new study ... Read more

May 4, 2018May 4, 2018

Biogen and Ionis Expand Collaboration to Develop Therapy Candidates for Alzheimer’s, Other Neurological Diseases

News

Biogen and Ionis Pharmaceuticals are expanding their strategic collaboration through a new 10-year agreement to develop novel RNA-targeted therapy candidates for a broad range of neurological diseases, including Alzheimer’s ... Read more

Pin It on Pinterest